{
    "eid": "2-s2.0-85112747292",
    "title": "Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083",
    "cover-date": "2021-11-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "cabotegravir",
        "HIV",
        "HPTN 083",
        "injectable",
        "long-acting",
        "men who have sex with men",
        "preexposure prophylaxis",
        "prevention",
        "TDF/FTC"
    ],
    "authors": [
        "Mark A. Marzinke",
        "Beatriz Grinsztejn",
        "Jessica M. Fogel",
        "Estelle Piwowar-Manning",
        "Maoji Li",
        "Lei Weng",
        "Marybeth McCauley",
        "Vanessa Cummings",
        "Shahnaz Ahmed",
        "Casey D. Haines",
        "Lane R. Bushman",
        "Christos Petropoulos",
        "Deborah Persaud",
        "Adeola Adeyeye",
        "Ryan Kofron",
        "Alex Rinehart",
        "Marty St Clair",
        "James F. Rooney",
        "Daniel Pryluka",
        "Lara Coelho",
        "Aditya Gaur",
        "Keren Middelkoop",
        "Nittaya Phanuphak",
        "Myron S. Cohen",
        "Craig W. Hendrix",
        "Peter Anderson",
        "Brett Hanscom",
        "Deborah Donnell",
        "Raphael J. Landovitz",
        "Susan H. Eshleman"
    ],
    "citedby-count": 55,
    "ref-count": 27,
    "ref-list": [
        "HIV preexposure prophylaxis: a review",
        "Preexposure chemoprophylaxis for HIV prevention in men who have sex with men",
        "Long-acting HIV drugs for treatment and prevention",
        "Cabotegravir: its potential for antiretroviral therapy and preexposure prophylaxis",
        "Longacting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial",
        "Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: patient perspectives from the ECLAIR trial",
        "Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial",
        "Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial",
        "HPTN 083 interim results: pre-exposure prophylaxis (PrEP) containing long-acting injectable cabotegravir (CAB-LA) is safe and highly effective for cisgender men and transgender women who have sex with men (MSM,TGW)",
        "Risk of drug resistance among persons acquiring HIV within a randomized clinical trial of singleor dual-agent preexposure prophylaxis",
        "Preexposure prophylaxis-selected drug resistance decays rapidly after drug cessation",
        "Characterization of HIV seroconverters in a TDF/FTC PrEP Study: HPTN 067/ ADAPT",
        "Should we fear resistance from tenofovir/emtricitabine preexposure prophylaxis?",
        "HIV drug resistance against strand transfer integrase inhibitors",
        "A simpler and more sensitive single-copy HIV-1 RNA assay for quantification of persistent HIV-1 viremia in Individuals on suppressive antiretroviral therapy",
        "2019 Update of the drug resistance mutations in HIV-1",
        "Long-acting integrase inhibitor protects macaques from intrarectal simian/human immunodeficiency virus",
        "Pharmacokinetics, safety, and monotherapy antiviral activity of GSK1265744, an HIV integrase strand transfer inhibitor",
        "Dose frequency ranging pharmacokinetic study of tenofovir-emtricitabine after directly observed dosing in healthy volunteers to establish adherence benchmarks (HPTN 066)",
        "Intracellular tenofovir-diphosphate and emtricitabinetriphosphate in dried blood spots following directly observed therapy",
        "A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge",
        "Study product adherence measurement in the iPrEx placebo-controlled trial: concordance with drug detection",
        "Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) study",
        "GSK1265744 pharmacokinetics in plasma and tissue after single-dose long-acting injectable administration in healthy subjects",
        "Genital abnormalities, hormonal contraception, and HIV transmission risk in Rwandan serodifferent couples"
    ],
    "affiliation": [
        {
            "affiliation-city": "Baltimore",
            "@id": "60001117",
            "affilname": "Johns Hopkins School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60001117",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Durham",
            "@id": "60120612",
            "affilname": "FHI 360",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60120612",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Brentford",
            "@id": "60110877",
            "affilname": "ViiV Healthcare",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60110877",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Aurora",
            "@id": "60028392",
            "affilname": "University of Colorado Anschutz Medical Campus",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028392",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Los Angeles",
            "@id": "60027550",
            "affilname": "University of California, Los Angeles",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027550",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Rio de Janeiro",
            "@id": "60023997",
            "affilname": "Instituto Nacional de Infectologia Evandro Chagas (INI)",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023997",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Memphis",
            "@id": "60019905",
            "affilname": "St. Jude Children's Research Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60019905",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "San Francisco",
            "@id": "60018313",
            "affilname": "Monogram Biosciences",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018313",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Raleigh",
            "@id": "60017717",
            "affilname": "The University of North Carolina System",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017717",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bethesda",
            "@id": "60017336",
            "affilname": "National Institute of Allergy and Infectious Diseases (NIAID)",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017336",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Los Angeles",
            "@id": "60005247",
            "affilname": "David Geffen School of Medicine at UCLA",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005247",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Seattle",
            "@id": "60003625",
            "affilname": "Fred Hutchinson Cancer Research Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60003625",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Foster City",
            "@id": "60002909",
            "affilname": "Gilead Sciences Incorporated",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002909",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Cape Town",
            "@id": "60000356",
            "affilname": "University of Cape Town",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000356",
            "affiliation-country": "South Africa"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "124379119",
            "affilname": "Institute of HIV Research and Innovation",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/124379119",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Buenos Aires",
            "@id": "101652054",
            "affilname": "Hospital Velez Sarfield",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/101652054",
            "affiliation-country": "Argentina"
        }
    ],
    "funding": [
        "National Institutes of Health",
        "National Institute of Mental Health",
        "National Institute on Drug Abuse",
        "National Institute of Allergy and Infectious Diseases",
        "Office of the Director"
    ]
}